• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Elscint's U.S. sales take bigger share

Article

Elscint has shown progressin increasing its position in the U.S. market. Historically, theIsraeli-based medical imaging vendor has been stronger in Europethan in the U.S. With scanner sales sagging in both markets, Elscintviews boosting its U.S. share as

Elscint has shown progressin increasing its position in the U.S. market. Historically, theIsraeli-based medical imaging vendor has been stronger in Europethan in the U.S. With scanner sales sagging in both markets, Elscintviews boosting its U.S. share as an opportunity to maintain itsrevenues.

The vendor saw revenue rise 8% in fiscal 1993 (end-December)to $238 million from $221 million in 1992. However, U.S. saleswere up nearly 50% for the year. Net income rose 7% -- not countingthe $4.8 million positive effect of a change in accounting methods-- from $20 million in 1992 to $21.5 million last year.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.